About the Company
We do not have any company description for Aptose Biosciences Inc. at the moment.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Aptose Biosciences Inc.
Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy
Safety Review Committee endorses escalation to 160 mg TUS dosingCohorts with 120 mg, 80 mg, 40 mg TUS dosing completed with ...
Aptose Receives $10 Million Through a Facility Agreement with Hanmi ...
For further information, please contact: Aptose Biosciences Inc. Susan Pietropaolo Corporate Communications & Investor Relations 201-923-2049 spietropaolo@aptose.com ...
Aptose Presents Highlights from Clinical Update Webcast Featuring ...
SAN DIEGO and TORONTO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...
Aptose Biosciences Advances Tuspetinib in AML Treatment with Promising Trial Results
The latest update is out from Aptose Biosciences ( (TSE:APS) ).
Aptose Biosciences Inc. (APTO) Q4 2023 Earnings Call Transcript
Aptose Biosciences Inc. (APTO) Q4 2023 Earnings Call Transcript Mar. 26, 2024 8:38 PM ET Aptose Biosciences Inc. (APTOF) Stock, APS:CA Stock APTOF, APS:CA SA Transcripts 153.57K Follower s ...
Aptose Biosciences Inc. Announces Reverse Share Split to ... - Nasdaq
Aptose Biosciences Inc. announced a plan to consolidate its outstanding common shares on a 1-for-30 basis, subject to regulatory approval, in an effort to comply with NASDAQ's minimum bid price ...
APTOF - Aptose Biosciences Inc News | Morningstar
Aptose Biosciences Inc APTOF Stock PINX Rating as of Apr 4, 2025 Download PDF Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics Financials Valuation Dividends ...
Aptose Biosciences Inc. Stock Grades | APTOF | Barron's
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small ...
APTOF - Aptose Biosciences Inc Dividends | Morningstar
Aptose Biosciences Inc APTOF Stock PINX Rating as of May 9, 2025 Download PDF Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics Financials Valuation Dividends ...
LTI0 | Aptose Biosciences Inc. Stock Overview (Germany: Frankfurt ...
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small ...
Similar Companies
Loading the latest forecasts...